Surviving sepsis guidelines: A continuous move toward better care of patients with sepsis

JAMA - Journal of the American Medical Association

Volumn 317, Issue 8, 2017, Pages 807-808

  De Backer, Daniel ^a   Dorman, Todd ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

CLINICAL PRACTICE; CRITICALLY ILL PATIENT; HEMODYNAMIC MONITORING; HUMAN; INFECTION CONTROL; MORTALITY RATE; NOTE; PATIENT CARE; POPULATION RISK; PRACTICE GUIDELINE; RESUSCITATION; SEPSIS; SEPTIC SHOCK; EVIDENCE BASED MEDICINE; INTENSIVE CARE; MORTALITY; STANDARDS; TREATMENT OUTCOME;

CRITICAL CARE; EVIDENCE-BASED MEDICINE; HUMANS; PATIENT CARE; PRACTICE GUIDELINES AS TOPIC; SEPSIS; TREATMENT OUTCOME;

EID: 85014703397     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.0059     Document Type: Note

References (10)

1. Kaukonen KM, BaileyM, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014;311 (13):1308-1316.
2. Levy MM, Rhodes A, Phillips GS, et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med. 2015;43(1):3-12.
3. Rhodes A, Evans L, AlhazzaniW, et al. Surviving Sepsis Campaign: international guidelines for the management of sepsis and septic shock: 2016. Crit Care Med. doi:10.1097/CCM.0000000000002255
4. Rhodes A, Evans L, AlhazzaniW, et al. Surviving Sepsis Campaign: international guidelines for the management of sepsis and septic shock: 2016. Intensive Care Med. doi:10.1007/s00134 -017-4683-6
5. Howell MD, Davis AM. Management of sepsis and septic shock. JAMA. doi:10.1001/jama.2017.0131
6. Angus DC, Barnato AE, Bell D, et al. A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, PROCESS and PROMISE Investigators. Intensive Care Med. 2015;41 (9):1549-1560.
7. Cecconi M, Hofer C, Teboul JL, et al; FENICE Investigators; ESICM Trial Group. Fluid challenges in intensive care: the FENICE study: a global inception cohort study. Intensive Care Med. 2015;41(9):1529-1537.
8. Roberts JA, Paul SK, AkovaM, et al; DALI Study. DALI: defining antibiotic levels in intensive care unit patients: are current ß-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis.2014;58(8):1072-1083.
9. Rhodes A, Phillips G, Beale R, et al. The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPRESS study). Intensive Care Med. 2015;41(9):1620-1628.
10. Surviving Sepsis Campaign. http://www.survivingsepsis.org.AccessedJanuary11,2017.